{Reference Type}: Journal Article
{Title}: MicroRNA for Prediction of Teratoma and Viable Germ Cell Tumor after Chemotherapy.
{Author}: Baky FJ;Matulewicz RS;Feldman DR;Hamilton RJ;Bagrodia A;
{Journal}: Urol Clin North Am
{Volume}: 51
{Issue}: 3
{Year}: 2024 Aug
{Factor}: 2.766
{DOI}: 10.1016/j.ucl.2024.03.007
{Abstract}: MicroRNAs (miRNAs) are emerging as highly sensitive and specific markers for testicular germ cell tumors (GCTs) across the spectrum of disease. However, their utility in specific clinical scenarios requires further study. Here, we review the current evidence for miRNAs as tumor markers for the evaluation of treatment response in patients undergoing chemotherapy for the treatment of advanced testicular GCT.